

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.89098088 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.44102871 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.44102871 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.00075449 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.53988584 |
| 6 | negative T cell selection (GO:0043383) | 5.36169156 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.34397340 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.18925599 |
| 9 | positive thymic T cell selection (GO:0045059) | 5.15120888 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.97752354 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.85952939 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.85952939 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85083673 |
| 14 | positive T cell selection (GO:0043368) | 4.69926968 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64091162 |
| 16 | response to interleukin-15 (GO:0070672) | 4.56988252 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 4.54377247 |
| 18 | T cell selection (GO:0045058) | 4.40435914 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 4.38485404 |
| 20 | leukocyte aggregation (GO:0070486) | 4.37863117 |
| 21 | thymic T cell selection (GO:0045061) | 4.36001883 |
| 22 | regulation of B cell differentiation (GO:0045577) | 4.28156252 |
| 23 | interferon-gamma production (GO:0032609) | 4.26597018 |
| 24 | T cell migration (GO:0072678) | 4.26572567 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 4.15369782 |
| 26 | ribosomal small subunit assembly (GO:0000028) | 4.03748699 |
| 27 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.00858915 |
| 28 | mast cell activation (GO:0045576) | 3.98519070 |
| 29 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.94057754 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.93174617 |
| 31 | T cell receptor signaling pathway (GO:0050852) | 3.89912357 |
| 32 | detection of bacterium (GO:0016045) | 3.86643615 |
| 33 | detection of other organism (GO:0098543) | 3.86203311 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84983190 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.84983190 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84983190 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84983190 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84983190 |
| 39 | modulation by symbiont of host immune response (GO:0052553) | 3.84983190 |
| 40 | T cell homeostasis (GO:0043029) | 3.82705814 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.82283145 |
| 42 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.78975297 |
| 43 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.76634109 |
| 44 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.76634109 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 3.73740691 |
| 46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.73256751 |
| 47 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.72083352 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 3.63825399 |
| 49 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.62744984 |
| 50 | tolerance induction (GO:0002507) | 3.59345110 |
| 51 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.59334086 |
| 52 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.59176604 |
| 53 | T cell costimulation (GO:0031295) | 3.55746067 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 3.55115867 |
| 55 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.52590209 |
| 56 | lymphocyte costimulation (GO:0031294) | 3.51155228 |
| 57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42716978 |
| 58 | lymphocyte homeostasis (GO:0002260) | 3.42559504 |
| 59 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.42053101 |
| 60 | negative regulation of phagocytosis (GO:0050765) | 3.39308698 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 3.38459338 |
| 62 | mast cell degranulation (GO:0043303) | 3.38366954 |
| 63 | mast cell activation involved in immune response (GO:0002279) | 3.38366954 |
| 64 | cellular extravasation (GO:0045123) | 3.33626027 |
| 65 | positive regulation of interleukin-2 production (GO:0032743) | 3.32018422 |
| 66 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.29054123 |
| 67 | neutrophil activation (GO:0042119) | 3.28155873 |
| 68 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.27483112 |
| 69 | respiratory burst (GO:0045730) | 3.24931814 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 3.22618481 |
| 71 | positive regulation of tolerance induction (GO:0002645) | 3.21630137 |
| 72 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.19102602 |
| 73 | regulation of cell killing (GO:0031341) | 3.18171032 |
| 74 | positive regulation of granulocyte differentiation (GO:0030854) | 3.17972790 |
| 75 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.16414039 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 3.16270852 |
| 77 | lymph node development (GO:0048535) | 3.16018091 |
| 78 | mature B cell differentiation (GO:0002335) | 3.11253123 |
| 79 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.10644637 |
| 80 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.10411624 |
| 81 | leukocyte homeostasis (GO:0001776) | 3.10079444 |
| 82 | B cell mediated immunity (GO:0019724) | 3.09947090 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.09749464 |
| 84 | myeloid cell activation involved in immune response (GO:0002275) | 3.08714955 |
| 85 | viral transcription (GO:0019083) | 3.08327705 |
| 86 | positive regulation of cell killing (GO:0031343) | 3.06345437 |
| 87 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04976904 |
| 88 | cytidine deamination (GO:0009972) | 3.03918407 |
| 89 | cytidine metabolic process (GO:0046087) | 3.03918407 |
| 90 | cytidine catabolic process (GO:0006216) | 3.03918407 |
| 91 | regulation of alpha-beta T cell activation (GO:0046634) | 3.02801300 |
| 92 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.02033314 |
| 93 | positive regulation of isotype switching (GO:0045830) | 3.01054927 |
| 94 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01007081 |
| 95 | detection of external biotic stimulus (GO:0098581) | 3.00574255 |
| 96 | response to type I interferon (GO:0034340) | 3.00424324 |
| 97 | defense response to protozoan (GO:0042832) | 2.99839392 |
| 98 | dendritic cell chemotaxis (GO:0002407) | 2.99796796 |
| 99 | cellular response to zinc ion (GO:0071294) | 2.99297192 |
| 100 | regulation of tolerance induction (GO:0002643) | 2.97877131 |
| 101 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.97857977 |
| 102 | granulocyte activation (GO:0036230) | 2.97307149 |
| 103 | leukocyte degranulation (GO:0043299) | 2.97245420 |
| 104 | response to protozoan (GO:0001562) | 2.96829337 |
| 105 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.96719504 |
| 106 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.95530021 |
| 107 | B cell homeostasis (GO:0001782) | 2.93884364 |
| 108 | cellular response to type I interferon (GO:0071357) | 2.93337921 |
| 109 | type I interferon signaling pathway (GO:0060337) | 2.93337921 |
| 110 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93090665 |
| 111 | cellular response to interferon-beta (GO:0035458) | 2.92386416 |
| 112 | dendritic cell migration (GO:0036336) | 2.91912823 |
| 113 | regulation of antigen processing and presentation (GO:0002577) | 2.91792125 |
| 114 | translational termination (GO:0006415) | 2.91789350 |
| 115 | regulation of granulocyte differentiation (GO:0030852) | 2.91622975 |
| 116 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91080325 |
| 117 | negative regulation of innate immune response (GO:0045824) | 2.90192897 |
| 118 | regulation of isotype switching (GO:0045191) | 2.89773655 |
| 119 | regulation of T cell mediated immunity (GO:0002709) | 2.89570120 |
| 120 | B cell proliferation (GO:0042100) | 2.87123033 |
| 121 | T cell differentiation (GO:0030217) | 2.86345398 |
| 122 | regulation of response to interferon-gamma (GO:0060330) | 2.84578710 |
| 123 | V(D)J recombination (GO:0033151) | 2.83144287 |
| 124 | myeloid dendritic cell activation (GO:0001773) | 2.82632912 |
| 125 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81793603 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.80528743 |
| 127 | natural killer cell activation (GO:0030101) | 2.80220087 |
| 128 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.78287126 |
| 129 | megakaryocyte development (GO:0035855) | 2.77560282 |
| 130 | immunoglobulin mediated immune response (GO:0016064) | 2.77499736 |
| 131 | leukocyte cell-cell adhesion (GO:0007159) | 2.77211285 |
| 132 | mature B cell differentiation involved in immune response (GO:0002313) | 2.75646659 |
| 133 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.73778650 |
| 134 | regulation of B cell mediated immunity (GO:0002712) | 2.70768560 |
| 135 | alpha-beta T cell activation (GO:0046631) | 2.69613476 |
| 136 | positive regulation of DNA recombination (GO:0045911) | 2.69152633 |
| 137 | T cell proliferation (GO:0042098) | 2.69029951 |
| 138 | positive regulation of immunoglobulin production (GO:0002639) | 2.67811162 |
| 139 | activated T cell proliferation (GO:0050798) | 2.66298193 |
| 140 | natural killer cell differentiation (GO:0001779) | 2.66072063 |
| 141 | regulation of interleukin-2 production (GO:0032663) | 2.65442019 |
| 142 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.64611748 |
| 143 | T cell activation (GO:0042110) | 2.64032921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.20881402 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.86333451 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.68394230 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.26140644 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.02252178 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44150734 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.42869017 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.22244984 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.94212602 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.91808590 |
| 11 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.79158402 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.77247697 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76150887 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.74383045 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.73555542 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.72974222 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.68229174 |
| 18 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.67838177 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63712279 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.63138644 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.47072144 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.43904477 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33434607 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.30414188 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.28197943 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.23458938 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17660912 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.15035946 |
| 29 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.14817098 |
| 30 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14385297 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.11103859 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09320831 |
| 33 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01463847 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01428442 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96392469 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.91903103 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89248014 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89016632 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88833329 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.86592621 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80421434 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73688373 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71227317 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.70204210 |
| 45 | * MAF_26560356_Chip-Seq_TH2_Human | 1.67978323 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65631407 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65323233 |
| 48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.64639806 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60056521 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.59368883 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.56631479 |
| 52 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.53935793 |
| 53 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53045557 |
| 54 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51089104 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51006612 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50646854 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48906980 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44817716 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44693244 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40000763 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34978428 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34410057 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.25838517 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25837642 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25364269 |
| 66 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.21429768 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.20954788 |
| 68 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.18194387 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18157712 |
| 70 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17176281 |
| 71 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16703410 |
| 72 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16286432 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15100015 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13705070 |
| 75 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.13176806 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12157466 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11052382 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10585989 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09994736 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09571839 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08936569 |
| 82 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.08407494 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06533041 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04626456 |
| 85 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04143182 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04112607 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98539407 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97252174 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97198239 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95715188 |
| 91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94819273 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94708296 |
| 93 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94022119 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93409642 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93211329 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92922722 |
| 97 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.91802494 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91431757 |
| 99 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.90523449 |
| 100 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90177406 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90169003 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89792309 |
| 103 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.89069705 |
| 104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88684586 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87160234 |
| 106 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87126249 |
| 107 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87054283 |
| 108 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.86755089 |
| 109 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.86520588 |
| 110 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86379652 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 0.86280771 |
| 112 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.84616747 |
| 113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84074893 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.83752598 |
| 115 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83640104 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83421120 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82183403 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81850435 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81728236 |
| 120 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.80648813 |
| 121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80351196 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79677966 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79504590 |
| 124 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.77925187 |
| 125 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.77289408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.28924557 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.28623513 |
| 3 | MP0005671_abnormal_response_to | 3.92135356 |
| 4 | MP0000685_abnormal_immune_system | 3.63980637 |
| 5 | MP0001800_abnormal_humoral_immune | 3.50327443 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.42029801 |
| 7 | MP0005387_immune_system_phenotype | 3.17318913 |
| 8 | MP0001790_abnormal_immune_system | 3.17318913 |
| 9 | MP0002420_abnormal_adaptive_immunity | 2.92277450 |
| 10 | MP0002398_abnormal_bone_marrow | 2.92079371 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.91148140 |
| 12 | MP0001819_abnormal_immune_cell | 2.87734778 |
| 13 | MP0002723_abnormal_immune_serum | 2.86656019 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.85318992 |
| 15 | MP0009785_altered_susceptibility_to | 2.75999921 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.74733579 |
| 17 | MP0000716_abnormal_immune_system | 2.56843579 |
| 18 | MP0005025_abnormal_response_to | 2.55866962 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.43071875 |
| 20 | MP0002722_abnormal_immune_system | 2.36632480 |
| 21 | MP0003436_decreased_susceptibility_to | 2.33456689 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.33433165 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.30674093 |
| 24 | MP0001873_stomach_inflammation | 2.28694201 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.21014507 |
| 26 | MP0002419_abnormal_innate_immunity | 2.19547515 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 2.19536915 |
| 28 | MP0002006_tumorigenesis | 2.19289661 |
| 29 | MP0002405_respiratory_system_inflammati | 2.17021026 |
| 30 | MP0002429_abnormal_blood_cell | 2.16061644 |
| 31 | MP0005464_abnormal_platelet_physiology | 2.12048108 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.07329693 |
| 33 | MP0003866_abnormal_defecation | 1.89849717 |
| 34 | MP0003303_peritoneal_inflammation | 1.81840345 |
| 35 | MP0001853_heart_inflammation | 1.71227255 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.70925832 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.70925832 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.70367478 |
| 39 | MP0003724_increased_susceptibility_to | 1.68213060 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.64876888 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.62562451 |
| 42 | MP0004947_skin_inflammation | 1.62143959 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.60139606 |
| 44 | MP0006082_CNS_inflammation | 1.57852651 |
| 45 | MP0000490_abnormal_crypts_of | 1.56175535 |
| 46 | MP0008057_abnormal_DNA_replication | 1.55686660 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.53722364 |
| 48 | MP0002933_joint_inflammation | 1.52763207 |
| 49 | MP0009278_abnormal_bone_marrow | 1.38678067 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.37827166 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.35600151 |
| 52 | MP0008058_abnormal_DNA_repair | 1.29653303 |
| 53 | MP0003077_abnormal_cell_cycle | 1.22230968 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.21345219 |
| 55 | MP0008260_abnormal_autophagy | 1.17828059 |
| 56 | MP0004510_myositis | 1.16813205 |
| 57 | MP0008469_abnormal_protein_level | 1.13029210 |
| 58 | MP0000858_altered_metastatic_potential | 1.11974983 |
| 59 | MP0005310_abnormal_salivary_gland | 1.11023988 |
| 60 | MP0002095_abnormal_skin_pigmentation | 1.10629611 |
| 61 | MP0000015_abnormal_ear_pigmentation | 1.05097355 |
| 62 | MP0008007_abnormal_cellular_replicative | 1.01705464 |
| 63 | MP0004883_abnormal_blood_vessel | 1.00272908 |
| 64 | MP0003183_abnormal_peptide_metabolism | 0.99297070 |
| 65 | MP0003045_fibrosis | 0.98081110 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 0.97504354 |
| 67 | MP0005451_abnormal_body_composition | 0.94139012 |
| 68 | MP0002132_abnormal_respiratory_system | 0.92017631 |
| 69 | MP0001533_abnormal_skeleton_physiology | 0.90914034 |
| 70 | MP0004381_abnormal_hair_follicle | 0.90813006 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.90121618 |
| 72 | MP0003111_abnormal_nucleus_morphology | 0.86502339 |
| 73 | MP0005166_decreased_susceptibility_to | 0.81020995 |
| 74 | MP0003448_altered_tumor_morphology | 0.80997610 |
| 75 | MP0003172_abnormal_lysosome_physiology | 0.79930633 |
| 76 | MP0004957_abnormal_blastocyst_morpholog | 0.78459049 |
| 77 | MP0003690_abnormal_glial_cell | 0.73896593 |
| 78 | MP0000313_abnormal_cell_death | 0.73136460 |
| 79 | MP0001851_eye_inflammation | 0.69826388 |
| 80 | MP0009764_decreased_sensitivity_to | 0.69785795 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 0.64632919 |
| 82 | MP0003075_altered_response_to | 0.64443852 |
| 83 | MP0001663_abnormal_digestive_system | 0.63921822 |
| 84 | MP0005164_abnormal_response_to | 0.63671166 |
| 85 | MP0002009_preneoplasia | 0.63544463 |
| 86 | MP0005390_skeleton_phenotype | 0.63525330 |
| 87 | MP0004130_abnormal_muscle_cell | 0.63258357 |
| 88 | MP0009763_increased_sensitivity_to | 0.62693044 |
| 89 | MP0002693_abnormal_pancreas_physiology | 0.61607070 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.60074224 |
| 91 | MP0000249_abnormal_blood_vessel | 0.59897506 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.59689253 |
| 93 | MP0006054_spinal_hemorrhage | 0.58163493 |
| 94 | MP0000477_abnormal_intestine_morphology | 0.57098417 |
| 95 | MP0010307_abnormal_tumor_latency | 0.55877116 |
| 96 | MP0000604_amyloidosis | 0.55732529 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.55428249 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.52312287 |
| 99 | MP0003252_abnormal_bile_duct | 0.51526261 |
| 100 | MP0008874_decreased_physiological_sensi | 0.50938085 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.50575324 |
| 102 | MP0002928_abnormal_bile_duct | 0.50485838 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.50019423 |
| 104 | MP0003786_premature_aging | 0.49710847 |
| 105 | MP0000350_abnormal_cell_proliferation | 0.49381949 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.49048632 |
| 107 | MP0003943_abnormal_hepatobiliary_system | 0.48840532 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.48278557 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.48222674 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.46370500 |
| 111 | MP0003795_abnormal_bone_structure | 0.46118218 |
| 112 | MP0005023_abnormal_wound_healing | 0.46108414 |
| 113 | MP0000371_diluted_coat_color | 0.45600168 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.44216073 |
| 115 | MP0003787_abnormal_imprinting | 0.43842304 |
| 116 | MP0008004_abnormal_stomach_pH | 0.42619907 |
| 117 | MP0003828_pulmonary_edema | 0.42230929 |
| 118 | MP0001191_abnormal_skin_condition | 0.41984074 |
| 119 | MP0008873_increased_physiological_sensi | 0.41770450 |
| 120 | MP0002083_premature_death | 0.40044210 |
| 121 | MP0000609_abnormal_liver_physiology | 0.39148409 |
| 122 | MP0002075_abnormal_coat/hair_pigmentati | 0.39142120 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.38795813 |
| 124 | MP0005621_abnormal_cell_physiology | 0.38362778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.29653335 |
| 2 | Recurrent bronchitis (HP:0002837) | 5.13411717 |
| 3 | IgM deficiency (HP:0002850) | 5.08307109 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.06221855 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 4.98044760 |
| 6 | Agammaglobulinemia (HP:0004432) | 4.83495370 |
| 7 | Recurrent viral infections (HP:0004429) | 4.79146023 |
| 8 | Chronic otitis media (HP:0000389) | 4.65606944 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.56168920 |
| 10 | B lymphocytopenia (HP:0010976) | 4.43465538 |
| 11 | Abnormality of B cell number (HP:0010975) | 4.43465538 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.42353550 |
| 13 | Abnormality of T cells (HP:0002843) | 4.40920149 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.23967027 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 4.13345102 |
| 16 | Thyroiditis (HP:0100646) | 4.01639971 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.98969822 |
| 18 | IgG deficiency (HP:0004315) | 3.92526177 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.90775066 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.90775066 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.86000952 |
| 22 | Lymphopenia (HP:0001888) | 3.84906489 |
| 23 | Meningitis (HP:0001287) | 3.83945731 |
| 24 | Combined immunodeficiency (HP:0005387) | 3.80785781 |
| 25 | Thrombocytosis (HP:0001894) | 3.76397452 |
| 26 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.68817855 |
| 27 | Myositis (HP:0100614) | 3.67671149 |
| 28 | Abnormality of the fingertips (HP:0001211) | 3.67423253 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.61697026 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.52631537 |
| 31 | Recurrent sinusitis (HP:0011108) | 3.46964001 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45659742 |
| 33 | Gastrointestinal stroma tumor (HP:0100723) | 3.40892676 |
| 34 | Inflammation of the large intestine (HP:0002037) | 3.39831471 |
| 35 | Nasal polyposis (HP:0100582) | 3.38439916 |
| 36 | Cellulitis (HP:0100658) | 3.37427397 |
| 37 | Gastrointestinal inflammation (HP:0004386) | 3.36914591 |
| 38 | Hypoplasia of the thymus (HP:0000778) | 3.34183495 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 3.29251117 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 3.24785596 |
| 41 | Eosinophilia (HP:0001880) | 3.24096307 |
| 42 | Chronic diarrhea (HP:0002028) | 3.21237294 |
| 43 | Abnormality of eosinophils (HP:0001879) | 3.17429853 |
| 44 | Vasculitis (HP:0002633) | 3.16248948 |
| 45 | Keratoconjunctivitis (HP:0001096) | 3.12868424 |
| 46 | Chronic sinusitis (HP:0011109) | 3.10252630 |
| 47 | Granulocytopenia (HP:0001913) | 3.06369408 |
| 48 | Pustule (HP:0200039) | 3.03756390 |
| 49 | Colitis (HP:0002583) | 3.02688289 |
| 50 | Recurrent skin infections (HP:0001581) | 3.01391516 |
| 51 | Lymphoma (HP:0002665) | 2.98409686 |
| 52 | Stomatitis (HP:0010280) | 2.97832838 |
| 53 | Abnormality of the nasal mucosa (HP:0000433) | 2.95561396 |
| 54 | Papilloma (HP:0012740) | 2.94406405 |
| 55 | Verrucae (HP:0200043) | 2.94406405 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.89509904 |
| 57 | Bronchitis (HP:0012387) | 2.89064682 |
| 58 | IgA deficiency (HP:0002720) | 2.85430277 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.84625180 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.84288245 |
| 61 | Autoimmune thrombocytopenia (HP:0001973) | 2.78310011 |
| 62 | Leukocytosis (HP:0001974) | 2.77895287 |
| 63 | Urticaria (HP:0001025) | 2.77364373 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.72958193 |
| 65 | Obstructive lung disease (HP:0006536) | 2.70700162 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70700162 |
| 67 | Gingivitis (HP:0000230) | 2.64986098 |
| 68 | Encephalitis (HP:0002383) | 2.64979038 |
| 69 | Arterial thrombosis (HP:0004420) | 2.61064089 |
| 70 | Hypochromic anemia (HP:0001931) | 2.59102946 |
| 71 | Pulmonary embolism (HP:0002204) | 2.58859009 |
| 72 | Petechiae (HP:0000967) | 2.57673949 |
| 73 | Increased IgE level (HP:0003212) | 2.46719258 |
| 74 | Anorexia (HP:0002039) | 2.45046326 |
| 75 | Emphysema (HP:0002097) | 2.44412740 |
| 76 | Gangrene (HP:0100758) | 2.39960122 |
| 77 | Epistaxis (HP:0000421) | 2.38399013 |
| 78 | Poikiloderma (HP:0001029) | 2.36210148 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.35933443 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.34951499 |
| 81 | Papilledema (HP:0001085) | 2.31981728 |
| 82 | Recurrent otitis media (HP:0000403) | 2.26495531 |
| 83 | Osteomyelitis (HP:0002754) | 2.25523443 |
| 84 | Basal cell carcinoma (HP:0002671) | 2.25419796 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.23219724 |
| 86 | Sepsis (HP:0100806) | 2.22644649 |
| 87 | Recurrent pneumonia (HP:0006532) | 2.20922708 |
| 88 | Hemoptysis (HP:0002105) | 2.18449888 |
| 89 | Acute hepatic failure (HP:0006554) | 2.18040816 |
| 90 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14679414 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 2.14409608 |
| 92 | Optic neuritis (HP:0100653) | 2.14409608 |
| 93 | Reticulocytopenia (HP:0001896) | 2.14224247 |
| 94 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.12910179 |
| 95 | Leukopenia (HP:0001882) | 2.12602670 |
| 96 | Hypoproteinemia (HP:0003075) | 2.09567572 |
| 97 | Periodontitis (HP:0000704) | 2.09034174 |
| 98 | Pulmonary infiltrates (HP:0002113) | 2.09005635 |
| 99 | Aplastic anemia (HP:0001915) | 2.08981175 |
| 100 | Abnormal number of erythroid precursors (HP:0012131) | 2.08348996 |
| 101 | Glomerulopathy (HP:0100820) | 2.08156348 |
| 102 | Chest pain (HP:0100749) | 2.07975695 |
| 103 | Episodic fever (HP:0001954) | 2.06903980 |
| 104 | Cheilitis (HP:0100825) | 2.05429511 |
| 105 | Skin ulcer (HP:0200042) | 2.04844737 |
| 106 | Abnormality of the prostate (HP:0008775) | 2.04568321 |
| 107 | Microcytic anemia (HP:0001935) | 2.02280316 |
| 108 | Restrictive lung disease (HP:0002091) | 2.01816318 |
| 109 | Stomach cancer (HP:0012126) | 2.01494815 |
| 110 | Neutropenia (HP:0001875) | 1.99446768 |
| 111 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.98186796 |
| 112 | Orchitis (HP:0100796) | 1.97672705 |
| 113 | Increased IgM level (HP:0003496) | 1.96524829 |
| 114 | Gingival bleeding (HP:0000225) | 1.96449075 |
| 115 | Entropion (HP:0000621) | 1.94862424 |
| 116 | Keratitis (HP:0000491) | 1.94553031 |
| 117 | Abnormality of macrophages (HP:0004311) | 1.94054606 |
| 118 | Skin rash (HP:0000988) | 1.92414514 |
| 119 | Viral hepatitis (HP:0006562) | 1.92243819 |
| 120 | Joint swelling (HP:0001386) | 1.92224610 |
| 121 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91653632 |
| 122 | Interstitial pulmonary disease (HP:0006530) | 1.91290610 |
| 123 | Polyneuropathy (HP:0001271) | 1.89064510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.81428741 |
| 2 | TXK | 3.97797601 |
| 3 | ZAP70 | 2.68468375 |
| 4 | JAK3 | 2.63647654 |
| 5 | BLK | 2.42138432 |
| 6 | TYK2 | 2.38876151 |
| 7 | BTK | 2.36206775 |
| 8 | KIT | 2.28148429 |
| 9 | TEC | 2.26635453 |
| 10 | GRK6 | 2.26083634 |
| 11 | ITK | 2.24730310 |
| 12 | STK10 | 2.14070592 |
| 13 | IKBKE | 2.11620791 |
| 14 | PRPF4B | 2.08608586 |
| 15 | SYK | 2.07462713 |
| 16 | MAP3K10 | 1.94872024 |
| 17 | EEF2K | 1.94005847 |
| 18 | MAP3K13 | 1.92814694 |
| 19 | IRAK4 | 1.90650136 |
| 20 | CSF1R | 1.87650683 |
| 21 | MAP3K14 | 1.85470154 |
| 22 | SIK2 | 1.75518607 |
| 23 | FGFR4 | 1.72104920 |
| 24 | LCK | 1.70587361 |
| 25 | NLK | 1.62322452 |
| 26 | JAK1 | 1.59751985 |
| 27 | TBK1 | 1.55004497 |
| 28 | SIK3 | 1.44076233 |
| 29 | HCK | 1.40711009 |
| 30 | FGFR3 | 1.35067365 |
| 31 | FES | 1.30155046 |
| 32 | CLK1 | 1.28675404 |
| 33 | RIPK4 | 1.28572863 |
| 34 | NME2 | 1.26992424 |
| 35 | LYN | 1.25980131 |
| 36 | LRRK2 | 1.24377381 |
| 37 | IKBKB | 1.23609202 |
| 38 | TGFBR2 | 1.22833031 |
| 39 | FGR | 1.22469723 |
| 40 | FLT3 | 1.20680729 |
| 41 | CSK | 1.20344325 |
| 42 | PIM1 | 1.18678708 |
| 43 | BMPR2 | 1.13948095 |
| 44 | MAP3K11 | 1.09544950 |
| 45 | CAMKK2 | 1.04031886 |
| 46 | KDR | 1.04012497 |
| 47 | MARK3 | 1.03977615 |
| 48 | TNK2 | 1.02114209 |
| 49 | EPHB1 | 1.02073235 |
| 50 | MAP2K3 | 0.99885216 |
| 51 | NEK2 | 0.94506488 |
| 52 | PRKCQ | 0.89679969 |
| 53 | STK16 | 0.88445297 |
| 54 | CAMKK1 | 0.88442308 |
| 55 | TGFBR1 | 0.77050330 |
| 56 | CDK4 | 0.76819445 |
| 57 | MAP3K3 | 0.76583762 |
| 58 | ERN1 | 0.74862322 |
| 59 | STK4 | 0.74213367 |
| 60 | TAOK3 | 0.74087989 |
| 61 | IRAK3 | 0.73017221 |
| 62 | RPS6KA4 | 0.72362347 |
| 63 | PKN2 | 0.70502450 |
| 64 | MAP3K12 | 0.67834480 |
| 65 | MST4 | 0.67143548 |
| 66 | BRD4 | 0.66604407 |
| 67 | MAP3K1 | 0.66191759 |
| 68 | PIK3CG | 0.66171992 |
| 69 | ATR | 0.65217597 |
| 70 | PRKCH | 0.64876780 |
| 71 | TLK1 | 0.64712942 |
| 72 | MAP3K7 | 0.64620558 |
| 73 | RPS6KB2 | 0.64441881 |
| 74 | JAK2 | 0.63761285 |
| 75 | ACVR1B | 0.62946537 |
| 76 | CHUK | 0.61640364 |
| 77 | TAOK1 | 0.60325762 |
| 78 | CDK12 | 0.59980657 |
| 79 | ADRBK2 | 0.59883515 |
| 80 | IRAK1 | 0.58796416 |
| 81 | MAP2K2 | 0.57050089 |
| 82 | TESK2 | 0.56615045 |
| 83 | HIPK2 | 0.54955454 |
| 84 | EIF2AK3 | 0.54781546 |
| 85 | GRK7 | 0.54407542 |
| 86 | PASK | 0.53650442 |
| 87 | MAPK11 | 0.53043881 |
| 88 | CDC42BPA | 0.49240292 |
| 89 | TNIK | 0.48471025 |
| 90 | YES1 | 0.47283865 |
| 91 | MAPK4 | 0.46878752 |
| 92 | PIM2 | 0.45038887 |
| 93 | MAPK7 | 0.43598462 |
| 94 | MAPK12 | 0.43596946 |
| 95 | PDK1 | 0.43056948 |
| 96 | MARK2 | 0.40401761 |
| 97 | SRPK1 | 0.38223004 |
| 98 | CDC7 | 0.37196504 |
| 99 | PDPK1 | 0.34578810 |
| 100 | DYRK1B | 0.34524925 |
| 101 | SCYL2 | 0.34329758 |
| 102 | PTK6 | 0.33982045 |
| 103 | RPS6KA6 | 0.33795472 |
| 104 | PTK2B | 0.32498708 |
| 105 | STK11 | 0.31885456 |
| 106 | SIK1 | 0.31561709 |
| 107 | TRPM7 | 0.30556808 |
| 108 | RPS6KL1 | 0.29958582 |
| 109 | RPS6KC1 | 0.29958582 |
| 110 | MAPKAPK2 | 0.29856416 |
| 111 | TAOK2 | 0.29840200 |
| 112 | EPHA3 | 0.29393760 |
| 113 | WEE1 | 0.28434963 |
| 114 | MAPK3 | 0.28312026 |
| 115 | MELK | 0.28100562 |
| 116 | ABL1 | 0.26896151 |
| 117 | CDK19 | 0.26794969 |
| 118 | MAP3K5 | 0.26212313 |
| 119 | MATK | 0.26106508 |
| 120 | VRK1 | 0.25307316 |
| 121 | EGFR | 0.24568280 |
| 122 | CDK6 | 0.24426205 |
| 123 | FYN | 0.24224911 |
| 124 | PRKD2 | 0.24111924 |
| 125 | RPS6KA5 | 0.23702899 |
| 126 | STK38 | 0.23271674 |
| 127 | MAP2K6 | 0.22986045 |
| 128 | INSR | 0.22822738 |
| 129 | PRKCD | 0.22299946 |
| 130 | IGF1R | 0.20718889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.55659943 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.74127705 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.60751935 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.56447148 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.50470307 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.38341689 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.37073955 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.36750883 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26760538 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.24501896 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20944185 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.15498259 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06488728 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.96348024 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.89188251 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.84387096 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.84202030 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.81340404 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.77404192 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77339841 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.59852111 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54404649 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53976445 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38933184 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.35848724 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35156641 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.30185858 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29855214 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29721610 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27785181 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24099690 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.23329821 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21467763 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.21168386 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.18505923 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14755216 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13637909 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13320536 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09897096 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.06396965 |
| 41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.06384850 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05948172 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.04316390 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01552491 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96152702 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 0.95334757 |
| 47 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94230045 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93768972 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92458931 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92395523 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 0.89389380 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89059395 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86877811 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86252976 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.85865125 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84379619 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81801372 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80946251 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80101757 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.77985843 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.77474915 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.76034028 |
| 63 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.75976287 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72017315 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 0.71118309 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.70210003 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.70014490 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67896124 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65722681 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63346410 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61260264 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.61113150 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61043441 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60602267 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59199478 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57063566 |
| 77 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.55826864 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.55060948 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.54493335 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.53780320 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53385173 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52202148 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51616450 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48646663 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48319894 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47483640 |
| 87 | RNA transport_Homo sapiens_hsa03013 | 0.46981518 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46344648 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44834367 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43225927 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43082794 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42866490 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41826173 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41645425 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41448494 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40120594 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39497999 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39346543 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39246599 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39094600 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37348692 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37227669 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36908371 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36695563 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36365452 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35753618 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35658586 |
| 108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.34046101 |
| 109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33782913 |
| 110 | Proteasome_Homo sapiens_hsa03050 | 0.33103807 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32912775 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32555971 |
| 113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31488416 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.30382980 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29327528 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28041726 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27968023 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27397816 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24734184 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.24428533 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22279370 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22113232 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21768730 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19685317 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19523515 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19234276 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16775881 |
| 128 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16632762 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14965056 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14742900 |
| 131 | Long-term potentiation_Homo sapiens_hsa04720 | 0.13961764 |

